Hydrogen sulfide regulates homocysteine-mediated glomerulosclerosis

American Journal of Nephrology

Volumn 31, Issue 5, 2010, Pages 442-455

  Sen, Utpal ^a   Munjal, Charu ^a   Qipshidze, Natia ^a   Abe, Oluwasegun ^a   Gargoum, Riyad ^a   Tyagi, Suresh C ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Collagen; Fibrosis; Hypertension; Inflammation; Matrix metalloproteinase; Renal dysfunction

Indexed keywords

COLLAGEN; CYSTATHIONINE BETA SYNTHASE; DRINKING WATER; GELATINASE A; GELATINASE B; HOMOCYSTEINE; HYDROGEN SULFIDE; INTERCELLULAR ADHESION MOLECULE 1; MATRIX METALLOPROTEINASE; PROTEIN P47; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SODIUM DITHIONITE; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; BLOOD PRESSURE; CONTROLLED STUDY; DOWN REGULATION; GENETIC MODEL; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; HETEROZYGOSITY; HYPERHOMOCYSTEINEMIA; KIDNEY DYSFUNCTION; KIDNEY INJURY; MACROPHAGE; MALE; MOUSE; NEPHRECTOMY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; UPREGULATION; WILD TYPE; ANIMAL; C57BL MOUSE; CHEMISTRY; INFLAMMATION; KIDNEY; KIDNEY DISEASES; METABOLISM; PATHOLOGY;

ANIMALS; COLLAGEN; CYSTATHIONINE BETA-SYNTHASE; DOWN-REGULATION; HOMOCYSTEINE; HYDROGEN SULFIDE; HYPERHOMOCYSTEINEMIA; INFLAMMATION; KIDNEY; KIDNEY DISEASES; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL;

EID: 77952260852     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000296717     Document Type: Article

References (54)

1. Lentz SR: Mechanisms of homocysteine-induced atherothrombosis. J Thromb Haemost 2005; 3: 1646-1654.
2. Dayal S, Bottiglieri T, Arning E, Maeda N, Malinow MR, Sigmund CD, Heistad DD, Faraci FM, Lentz SR: Endothelial dysfunction and elevation of S-adenosylhomocysteine in cystathionine beta-synthase-deficient mice. Circ Res 2001; 88: 1203-1209.
3. Diez N, Perez R, Hurtado V, Santidrian S: Hyperhomocysteinaemia induced by dietary folate restriction causes kidney oxidative stress in rats. Br J Nutr 2005; 94: 204-210.
4. Zhang F, Siow YL : Hyperhomocysteinemia activates NF-kappaB and inducible nitric oxide synthase in the kidney. Kidney Int 2004; 65: 1327-1338. (Pubitemid 38406971)
5. Yi F, Li PL: Mechanisms of homocysteineinduced glomerular injury and sclerosis. Am J Nephrol 2008; 28: 254-264.
6. Shibuya N, Mikami Y, Kimura Y, Nagahara N, Kimura H: Vascular endothelium expresses 3-mercaptopyruvate sulfurtransferase and produces hydrogen sulfide. J Biochem 2009; 146: 623-626.
7. Shibuya N, Tanaka M, Yoshida M, Ogasawara Y, Togawa T, Ishii K, Kimura H: 3-mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain. Antioxid Redox Signal 2009; 11: 703-714.
8. Geng B, Yang J, Qi Y, Zhao J, Pang Y, Du J, Tang C: H 2 S generated by heart in rat and its effects on cardiac function. Biochem Biophys Res Commun 2004; 313: 362-368.
9. Swaroop M, Bradley K, Ohura T, Tahara T, Roper MD, Rosenberg LE, Kraus JP: Rat cystathionine beta-synthase. Gene organization and alternative splicing. J Biol Chem 1992; 267: 11455-11461.
10. Lowicka E, Beltowski J: Hydrogen sulfide (H 2 S)-the third gas of interest for pharmacologists. Pharmacol Rep 2007; 59: 4-24.
11. Kimura Y, Dargusch R, Schubert D, Kimura H: Hydrogen sulfide protects HT22 neuronal cells from oxidative stress. Antioxid Redox Signal 2006; 8: 661-670.
12. Yonezawa D, Sekiguchi F, Miyamoto M, Taniguchi E, Honjo M, Masuko T, Nishikawa H, Kawabata A: A protective role of hydrogen sulfide against oxidative stress in rat gastric mucosal epithelium. Toxicology 2007; 241: 11-18.
13. Wei HL, Zhang CY, Jin HF, Tang CS, Du JB: Hydrogen sulfide regulates lung tissue-oxidized glutathione and total antioxidant capacity in hypoxic pulmonary hypertensive rats. Acta Pharmacol Sin 2008; 29: 670-679.
14. Fu Z, Liu X, Geng B, Fang L, Tang C: Hydrogen sulfide protects rat lung from ischemiareperfusion injury. Life Sci 2008; 82: 1196-1202.
15. Zanardo RC, Brancaleone V, Distrutti E, Fiorucci S, Cirino G, Wallace JL: Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J 2006; 20: 2118-2120.
16. Hu LF, Wong PT, Moore PK, Bian JS: Hydrogen sulfide attenuates lipopolysaccharideinduced inflammation by inhibition of p38 mitogen-activated protein kinase in microglia. J Neurochem 2007; 100: 1121-1128.
17. Rao VH, Lees GE, Kashtan CE, Nemori R, Singh RK, Meehan DT, Rodgers K, Berridge BR, Bhattacharya G, Cosgrove D: Increased expression of MMP-2, MMP-9 (type IV collagenases/ gelatinases), and MT1-MMP in canine X-linked Alport syndrome (XLAS). Kidney Int 2003; 63: 1736-1748.
18. Sen U, Basu P, Abe OA, Givvimani S, Tyagi N, Metreveli N, Shah KS, Passmore JC, Tyagi SC: Hydrogen sulfide ameliorates hyperhomocysteinemia- associated chronic renal failure. Am J Physiol Renal Physiol 2009; 297:F410-F419.
19. Sen U, Tyagi N, Kumar M, Moshal KS, Rodriguez WE, Tyagi SC: Cystathionine-betasynthase gene transfer and 3-deazaadenosine ameliorate inflammatory response in endothelial cells. Am J Physiol Cell Physiol 2007; 293:C1779-C1787.
20. Silverman MD, Tumuluri RJ, Davis M, Lopez G, Rosenbaum JT, Lelkes PI: Homocysteine upregulates vascular cell adhesion molecule-1 expression in cultured human aortic endothelial cells and enhances monocyte adhesion. Arterioscler Thromb Vasc Biol 2002; 22: 587-592.
21. Hofmann MA, Lalla E, Lu Y, Gleason MR, Wolf BM, Tanji N, Ferran LJ Jr, Kohl B, Rao V, Kisiel W, Stern DM, Schmidt AM: Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J Clin Invest 2001; 107: 675-683.
22. Kikuchi Y, Imakiire T, Yamada M, Saigusa T, Hyodo T, Hyodo N, Suzuki S, Miura S: Mizoribine reduces renal injury and macrophage infiltration in non-insulin-dependent diabetic rats. Nephrol Dial Transplant 2005; 20: 1573-1581.
23. Richardson CJ, Magee EA, Cummings JH: A new method for the determination of sulphide in gastrointestinal contents and whole blood by microdistillation and ion chromatography. Clin Chim Acta 2000; 293: 115-125.
24. Li L, Bhatia M, Zhu YZ, Zhu YC, Ramnath RD, Wang ZJ, Anuar FB, Whiteman M, Salto-Tellez M, Moore PK: Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse. FASEB J 2005; 19: 1196-1198.
25. Maezawa Y, Yokote K, Sonezaki K, Fujimoto M, Kobayashi K, Kawamura H, Tokuyama T, Takemoto M, Ueda S, Kuwaki T, Mori S, Wahren J, Saito Y: Influence of C-peptide on early glomerular changes in diabetic mice. Diabetes Metab Res Rev 2006; 22: 313-322.
26. Lorenz JN, Gruenstein E: A simple, nonradioactive method for evaluating singlenephron filtration rate using FITC-inulin. Am J Physiol 1999; 276:F172-F177.
27. Rodriguez WE, Tyagi N, Joshua IG, Passmore JC, Fleming JT, Falcone JC, Tyagi SC: Pioglitazone mitigates renal glomerular vascular changes in high-fat, high-calorie-induced type 2 diabetes mellitus. Am J Physiol Renal Physiol 2006; 291:F694-F701.
28. Li N, Chen YF, Zou AP: Implications of hyperhomocysteinemia in glomerular sclerosis in hypertension. Hypertension 2002; 39: 443-448.
29. Rodionov RN, Lentz SR: The homocysteine paradox. Arterioscler Thromb Vasc Biol 2008; 28: 1031-1033.
30. Schiffrin EL, Lipman ML, Mann JF: Chronic kidney disease: effects on the cardiovascular system. Circulation 2007; 116: 85-97.
31. Friedman AN, Bostom AG, Selhub J, Levey AS, Rosenberg IH: The kidney and homocysteine metabolism. J Am Soc Nephrol 2001; 12: 2181-2189.
32. Yang G, Wu L, Jiang B, Yang W, Qi J, Cao K, Meng Q, Mustafa AK, Mu W, Zhang S, Snyder SH, Wang R: H 2 S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science 2008; 322: 587-590.
33. Fang L, Li H, Tang C, Geng B, Qi Y, Liu X: Hydrogen sulfide attenuates the pathogenesis of pulmonary fibrosis induced by bleomycin in rats. Can J Physiol Pharmacol 2009; 87: 531-538.
34. Mishra PK, Tyagi N, Sen U, Givvimani S, Tyagi SC: H 2 S ameliorates oxidative and proteolytic stresses and protects the heart against adverse remodeling in chronic heart failure. Am J Physiol Heart Circ Physiol 2010; 298:H451-H456.
35. Stabler SP, Steegborn C, Wahl MC, Oliveriusova J, Kraus JP, Allen RH, Wagner C, Mudd SH: Elevated plasma total homocysteine in severe methionine adenosyltransferase I/III deficiency. Metabolism 2002; 51: 981-988.
36. Chang L, Geng B, Yu F, Zhao J, Jiang H, Du J, Tang C: Hydrogen sulfide inhibits myocardial injury induced by homocysteine in rats. Amino Acids 2008; 34: 573-585.
37. Jakubowski H: Protein homocysteinylation: possible mechanism underlying pathological consequences of elevated homocysteine levels. FASEB J 1999; 13: 2277-2283.
38. Jacobsen DW: Hyperhomocysteinemia and oxidative stress: Time for a reality check? Arterioscler Thromb Vasc Biol 2000; 20: 1182-1184.
39. Jacobsen DW, Troxell LS, Brown KL: Catalysis of thiol oxidation by cobalamins and cobinamides-reaction-products and kinetics. Biochemistry 1984; 23: 2017-2025.
40. Misra HP: Generation of superoxide free radical during the autoxidation of thiols. J Biol Chem 1974; 249: 2151-2155.
41. Brezniceanu ML, Liu F, Wei CC, Chenier I, Godin N, Zhang SL, Filep JG, Ingelfinger JR, Chan JS: Attenuation of interstitial fibrosis and tubular apoptosis in db/db transgenic mice overexpressing catalase in renal proximal tubular cells. Diabetes 2008; 57: 451-459.
42. Griendling KK, Sorescu D, Lassegue B, Ushio-Fukai M: Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol 2000; 20: 2175-2183.
43. Brandes RP, Kreuzer J: Vascular NADPH oxidases: molecular mechanisms of activation. Cardiovasc Res 2005; 65: 16-27.
44. Takeya R, Ueno N, Kami K, Taura M, Kohjima M, Izaki T, Nunoi H, Sumimoto H: Novel human homologues of p47 phox and p67 phox participate in activation of superoxide-producing NADPH oxidases. J Biol Chem 2003; 278: 25234-25246.
45. Madamanchi NR, Vendrov A, Runge MS: Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 2005; 25: 29-38.
46. Sellmayer A, Obermeier H, Danesch U, Aepfelbacher M, Weber PC: Arachidonic acid increases activation of NADPH oxidase in monocytic U937 cells by accelerated translocation of p47-phox and co-stimulation of protein kinase C. Cell Signal 1996; 8: 397-402.
47. Ungvari Z, Csiszar A, Edwards JG, Kaminski PM, Wolin MS, Kaley G, Koller A: Increased superoxide production in coronary arteries in hyperhomocysteinemia: role of tumor necrosis factor-alpha, NAD(P)H oxidase, and inducible nitric oxide synthase. Arterioscler Thromb Vasc Biol 2003; 23: 418-424.
48. Yi F, Zhang AY, Janscha JL, Li PL, Zou AP: Homocysteine activates NADH/NADPH oxidase through ceramide-stimulated Rac GTPase activity in rat mesangial cells. Kidney Int 2004; 66: 1977-1987.
49. Endo T, Nakabayashi K, Sekiuchi M, Kuroda T, Soejima A, Yamada A: Matrix metalloproteinase-2, matrix metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in the peripheral blood of patients with various glomerular diseases and their implication in pathogenetic lesions: study based on an enzyme-linked assay and immunohistochemical staining. Clin Exp Nephrol 2006; 10: 253-261.
50. Rysz J, Banach M, Stolarek RA, Pasnik J, Cialkowska-Rysz A, Koktysz R, Piechota M, Baj Z: Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy. J Nephrol 2007; 20: 444-452.
51. Senior RM, Griffin GL, Fliszar CJ, Shapiro SD, Goldberg GI, Welgus HG: Human 92-and 72-kilodalton type IV collagenases are elastases. J Biol Chem 1991; 266: 7870-7875.
52. Camp TM, Tyagi SC, Senior RM, Hayden MR: Gelatinase B(MMP-9) an apoptotic factor in diabetic transgenic mice. Diabetologia 2003; 46: 1438-1445.
53. Bonventre JV: Pathophysiology of acute kidney injury: roles of potential inhibitors of inflammation. Contrib Nephrol 2007; 156: 39-46.
54. Anderson JA, Lentsch AB, Hadjiminas DJ, Miller FN, Martin AW, Nakagawa K, Edwards MJ: The role of cytokines, adhesion molecules, and chemokines in interleukin-2-induced lymphocytic infiltration in C57BL/6 mice. J Clin Invest 1996; 97: 1952-1959.